Citation Impact

Citing Papers

The clinical symptoms of Parkinson's disease
2016 Standout
Depression
2018 Standout
Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders
2015
Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis
2008
Quetiapine in the treatment of schizophrenia and related disorders
2007
A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression
2010
Review of Pharmacological Treatment in Mood Disorders and Future Directions for Drug Development
2011
Self-referential processing in our brain—A meta-analysis of imaging studies on the self
2006 Standout
Schizophrenia
2009 Standout
Motivation and treatment engagement intervention trial (MotivaTe-IT): the effects of motivation feedback to clinicians on treatment engagement in patients with severe mental illness
2012
Transfer of Sulfur: From Simple to Diverse
2013 Standout
Effectiveness of psychotropic medications in the maintenance phase of bipolar disorder: a meta-analysis of randomized controlled trials
2011
Sleep Disorders Associated with Parkinson's Disease:Role of Dopamine, Epidemiology, and Clinical Scales of Assessment
2008
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research
2009 Standout
National Trends in the Outpatient Treatment of Children and Adolescents With Antipsychotic Drugs
2006
Haloperidol Addition in Fluvoxamine-Refractory Obsessive-Compulsive Disorder
1994
Power failure: why small sample size undermines the reliability of neuroscience
2013 Standout
Treatment-emergent mania in unipolar and bipolar depression: focus on repetitive transcranial magnetic stimulation
2007
Adverse Effects of Atypical Antipsychotics
2007
Pharmacological Treatment of Bipolar Depression: Qualitative Systematic Review of Double-Blind Randomized Clinical Trials
2011
Restoring invisible and abandoned trials: a call for people to publish the findings
2013
Buprenorphine and methadone maintenance in jail and post-release: A randomized clinical trial
2008
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
2013 Standout
Identifying HAM‐A cutoffs for mild, moderate, and severe generalized anxiety disorder
2010
Equally increased risk for metabolic syndrome in patients with bipolar disorder and schizophrenia treated with second‐generation antipsychotics
2008
Methadone Versus Buprenorphine With Contingency Management or Performance Feedback for Cocaine and Opioid Dependence
2005
Elevated Cerebrospinal Fluid Levels of Oxytocin in Obsessive-compulsive Disorder
1994
Sulfur Containing Scaffolds in Drugs: Synthesis and Application in Medicinal Chemistry
2016 Standout
Extended vs Short-term Buprenorphine-Naloxone for Treatment of Opioid-Addicted Youth
2008
Industry sponsorship and research outcome
2012 Standout
Results of a pilot randomized controlled trial of buprenorphine for opioid dependent women in the criminal justice system
2011
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence
2009
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
2016 Standout
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
2014 Standout
Just-in-Time Adaptive Interventions (JITAIs) in Mobile Health: Key Components and Design Principles for Ongoing Health Behavior Support
2016 Standout
A fuzzy cognitive map of the psychosocial determinants of obesity
2012 Standout
The Prescription Opioid and Heroin Crisis: A Public Health Approach to an Epidemic of Addiction
2015 Standout
Neuroleptic malignant syndrome and catatonia: One entity or two?
1996
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
2011 Standout
Office-Based Treatment of Opiate Addiction with a Sublingual-Tablet Formulation of Buprenorphine and Naloxone
2003
Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder
2008 Standout
The Role of Adenosine 3′,5′-Phosphate in Mediating Effects of Thyroid-stimulating Hormone on Carbohydrate Metabolism of Bovine Thyroid Slices
1968 StandoutNobel
Malignant catatonia
1994
The Oxytocin Receptor System: Structure, Function, and Regulation
2001 Standout
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
2016 Standout
EFFECTS OF THYROTROPIC HORMONE ON CARBOHYDRATE METABOLISM IN THYROID SLICES*
1963
Medication Adherence Measures: An Overview
2015 Standout
The Neuropsychiatric Inventory
1997 Standout
Industry sponsorship and research outcome
2017 Standout
What are validated self-report adherence scales really measuring?: a systematic review
2013
Prescribed drugs containing nitrogen heterocycles: an overview
2020 Standout

Works of Wayne Macfadden being referenced

A randomized, double‐blind, placebo‐controlled study of maintenance treatment with adjunctive risperidone long‐acting therapy in patients with bipolar I disorder who relapse frequently
2009
Effects of buprenorphine and naloxone in morphine-stabilized opioid addicts
1998
Assessment of Clinician Awareness of Nonadherence Using a New Structured Rating Scale
2010
Efficacy of Quetiapine Monotherapy in Bipolar I and II Depression
2006
A Randomized, Double-Blind, Placebo-Controlled Trial of Quetiapine in the Treatment of Bipolar I or II Depression
2005
THE FRACTIONATION OF EXOGENOUS AND ENDOGENOUS THYROID-STIMULATING HORMONE FROM HUMAN AND RAT PLASMA AND TISSUES*
1961
Neuroleptic Malignant Syndrome: Diagnostic Issues
1991
Methadone and edema.
1990
Rankless by CCL
2026